KYVERNA THERAPEUTICS INC (KYTX)
US5019761049 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to KYTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 44.88. This target is 540.69% above the current price.
KYTX was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about KYTX.
In the previous month the buy percentage consensus was at a similar level.
KYTX was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-07-03 | HC Wainwright & Co. | Initiate | Neutral |
| 2024-03-04 | JP Morgan | Initiate | Overweight |
| 2024-03-04 | Morgan Stanley | Initiate | Overweight |